Log In
Print
BCIQ
Print
Print this Print this
 

VC-01

  Manage Alerts
Collapse Summary General Information
Company ViaCyte Inc.
DescriptionPEC-01 cells, which are human embryonic stem cell (hESC)-derived pancreatic progenitor cells, encapsulated in ViaCyte's implantable Encaptra delivery system
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$20.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today